Inventor · disambiguated record
Lingkai Weng
Also filed as: WENG LINGKAI
15 granted patents·4 pending applications·142 citations·filing 2009–2024
93Inventor score
Top patents by PatentIndex Score
19 records- 0196US8420645B2Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the sameWENG LINGKAI·Filed 2009·Granted Apr 16, 2013·49 cites·16 claims
- 0295US8796319B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseCOMBS ANDREW P·Filed 2011·Granted Aug 5, 2014·21 cites·68 claims
- 0394US11084822B2Salts and processes of preparing a PI3K inhibitorINCYTE CORP·Filed 2019·Granted Aug 10, 2021·7 cites·37 claims
- 0494US10336759B2Salts and processes of preparing a PI3K inhibitorINCYTE CORP·Filed 2016·Granted Jul 2, 2019·18 cites·8 claims
- 0592US9321755B2Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitorINCYTE CORP·Filed 2014·Granted Apr 26, 2016·15 cites·66 claims
- 0692US8901123B2Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-B][1,2,4]triazin-2-yl]benzamide and processes related to preparing the sameWENG LINGKAI·Filed 2013·Granted Dec 2, 2014·14 cites·3 claims
- 0791US10245265B2Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-B][1,2,4]triazin-2-yl]benzamide and processes related to preparing the sameINCYTE CORP·Filed 2016·Granted Apr 2, 2019·6 cites·24 claims
- 0889US12024522B2Salts and processes of preparing a PI3K inhibitorINCYTE CORP·Filed 2021·Granted Jul 2, 2024·1 cites·48 claims
- 0988US2024173303A11,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- DioxygenaseINCYTE CORP·Filed 2023·Application pending·0 cites
- 1087US10799509B2Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-B][1,2,4]triazin-2-yl]benzamide and processes related to preparing the sameINCYTE CORP·Filed 2019·Granted Oct 13, 2020·3 cites·3 claims
- 1186US11207302B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseINCYTE CORP·Filed 2020·Granted Dec 28, 2021·1 cites·20 claims
- 1285US10280157B2Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitorINCYTE CORP·Filed 2017·Granted May 7, 2019·3 cites·12 claims
- 1383US12427154B2Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the sameINCYTE CORP·Filed 2022·Granted Sep 30, 2025·0 cites·20 claims
- 1481US9873688B2Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitorINCYTE CORP·Filed 2016·Granted Jan 23, 2018·2 cites·6 claims
- 1581US9732097B2Process for the synthesis of a phosphoinositide 3-kinase inhibitorINCYTE CORP·Filed 2016·Granted Aug 15, 2017·2 cites·39 claims
- 1680US2025129079A1Salts and processes of preparing a pi3k inhibitorINCYTE CORP·Filed 2024·Application pending·0 cites
- 1780US2022331296A11,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- DioxygenaseINCYTE CORP·Filed 2021·Application pending·0 cites
- 1875US11452726B2Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the sameINCYTE CORP·Filed 2020·Granted Sep 27, 2022·0 cites·6 claims
- 1966US2015148348A1Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the sameINCYTE CORP·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lingkai Weng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →